HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[An absence of interaction of sulfametrol-trimethoprim with insulin or sulphonylurea derivatives in diabetics (author's transl)].

Abstract
Since diabetics frequently suffer from urinary tract infections which can be successfully treated with a combination of sulphonamide derivatives and the bacteriocide trimethoprim, the question of possible interactions between such agents and diabetic therapy is of interest. A double-blind crossover trial was, therefore, carried out in 10 diabetics who were being treated with insulin, and 10 who were under treatment with sulphonylurea derivatives. Sulfametrol was administered in combination with trimethoprim (= Lidaprim). The blood glucose level was determined 3 times daily. No tendency towards hypoglycaemia was observed under treatment with the active agent in either group of patients. Within 5 days creatinine and blood urea nitrogen had increased to pathological levels in those patients who showed previous renal damage. It is concluded that the lack of interaction of these drugs with diabetes therapy justifies the use of these chemotherapeutic agents in diabetics. They are effective and relatively inexpensive in comparison with other agents. Subjective tolerance is also good.
AuthorsL Kaspar
JournalWiener klinische Wochenschrift (Wien Klin Wochenschr) Vol. 92 Issue 8 Pg. 276-9 (Apr 11 1980) ISSN: 0043-5325 [Print] Austria
Vernacular TitleFehlende Interaktion von Sulfametrol-Teimethoprim mit Insulin oder Sulfonylharnstoffderivaten bei der Behandlung von Diabetikern.
PMID6996341 (Publication Type: Clinical Trial, Controlled Clinical Trial, English Abstract, Journal Article)
Chemical References
  • Insulin
  • Sulfonylurea Compounds
  • Trimethoprim
  • Sulfamethoxazole
Topics
  • Diabetes Complications
  • Diabetes Mellitus (drug therapy)
  • Drug Interactions
  • Female
  • Humans
  • Insulin (therapeutic use)
  • Middle Aged
  • Sulfamethoxazole (therapeutic use)
  • Sulfonylurea Compounds (therapeutic use)
  • Trimethoprim (therapeutic use)
  • Urinary Tract Infections (drug therapy, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: